Amneal Pharmaceuticals, Class Stock Probability of Future Stock Price Finishing Over 8.32
| AMRX Stock | USD 8.32 0.09 1.07% |
Amneal |
Amneal Pharmaceuticals, Target Price Odds to finish over 8.32
The tendency of Amneal Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 8.32 | 90 days | 8.32 | about 84.13 |
Based on a normal probability distribution, the odds of Amneal Pharmaceuticals, to move above the current price in 90 days from now is about 84.13 (This Amneal Pharmaceuticals, Class probability density function shows the probability of Amneal Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Amneal Pharmaceuticals, has a beta of 0.96. This suggests Amneal Pharmaceuticals, Class market returns are sensitive to returns on the market. As the market goes up or down, Amneal Pharmaceuticals, is expected to follow. Additionally Amneal Pharmaceuticals, Class has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Amneal Pharmaceuticals, Price Density |
| Price |
Predictive Modules for Amneal Pharmaceuticals,
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Amneal Pharmaceuticals,. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Amneal Pharmaceuticals, Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Amneal Pharmaceuticals, is not an exception. The market had few large corrections towards the Amneal Pharmaceuticals,'s value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Amneal Pharmaceuticals, Class, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Amneal Pharmaceuticals, within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.06 | |
β | Beta against Dow Jones | 0.96 | |
σ | Overall volatility | 0.22 | |
Ir | Information ratio | -0.03 |
Amneal Pharmaceuticals, Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Amneal Pharmaceuticals, for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Amneal Pharmaceuticals, can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Amneal Pharmaceuticals, generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 2.39 B. Net Loss for the year was (48.72 M) with profit before overhead, payroll, taxes, and interest of 791.46 M. | |
| Amneal Pharmaceuticals, has a strong financial position based on the latest SEC filings | |
| About 53.0% of the company shares are held by company insiders | |
| Latest headline from zacks.com: AMNEAL PHARMACEUTICALS, INC. Hit a 52 Week High, Can the Run Continue |
Amneal Pharmaceuticals, Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Amneal Stock often depends not only on the future outlook of the current and potential Amneal Pharmaceuticals,'s investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Amneal Pharmaceuticals,'s indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 176.1 M | |
| Cash And Short Term Investments | 91.5 M |
Amneal Pharmaceuticals, Technical Analysis
Amneal Pharmaceuticals,'s future price can be derived by breaking down and analyzing its technical indicators over time. Amneal Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Amneal Pharmaceuticals, Class. In general, you should focus on analyzing Amneal Stock price patterns and their correlations with different microeconomic environments and drivers.
Amneal Pharmaceuticals, Predictive Forecast Models
Amneal Pharmaceuticals,'s time-series forecasting models is one of many Amneal Pharmaceuticals,'s stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Amneal Pharmaceuticals,'s historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Amneal Pharmaceuticals,
Checking the ongoing alerts about Amneal Pharmaceuticals, for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Amneal Pharmaceuticals, help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Amneal Pharmaceuticals, generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 2.39 B. Net Loss for the year was (48.72 M) with profit before overhead, payroll, taxes, and interest of 791.46 M. | |
| Amneal Pharmaceuticals, has a strong financial position based on the latest SEC filings | |
| About 53.0% of the company shares are held by company insiders | |
| Latest headline from zacks.com: AMNEAL PHARMACEUTICALS, INC. Hit a 52 Week High, Can the Run Continue |
Additional Tools for Amneal Stock Analysis
When running Amneal Pharmaceuticals,'s price analysis, check to measure Amneal Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amneal Pharmaceuticals, is operating at the current time. Most of Amneal Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of Amneal Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amneal Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of Amneal Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.